Inside the financial sector, the iShares U.S. Broker-Dealer & Securities Exchanges exchange-traded fund is stealing the ...

Roivant Sciences Ltd. (NASDAQ:ROIV) is one of the best biotech stocks to buy according to billionaire Steve Cohen.

Rahul Jain, Head of India Equity Research & Asia Financials at Goldman Sachs, told NDTV Profit that FY27 will be 'very strong ...

Sharp increases in speculative trading activity historically signal above-average near-term equity returns but poor ...

Investing.com -- Goldman Sachs has initiated coverage on Gubra A/S with a “neutral” rating and a 12-month price target of Dkr520, representing a 23.9% upside from the current price of Dkr419.80, in a ...

The cuts had been pencilled in for September if there was any severe economic turmoil from President Trump’s tariff and trade ...

"During the last 35 years, other sharp increases in speculative trading activity have signaled above-average subsequent 3-, 6-, and 12-month S&P 500 returns, but returns typically faltered on a ...

Emerging markets are set for further gains as renewed appetite for diversification and light positioning bolster the case for ...

The offering, expected to close on July 28, 2025, will allow Apollo to reduce its stake in the company. Underwriters will have a 30-day option to purchase an additional 10.65 million shares from the ...

Some analysts remain optimistic about continued market strength. Scott Rubner from Citadel Securities indicated retail traders could provide support for the rally. Tully suggested that if the Fed ...

Wall Street is waking up to a mixed market mood this Friday as U.S. stock futures edge higher, with the Dow Jones and S&P 500 inching closer to fresh record highs. The Nasdaq, however, is under ...

Shares of global manufacturing solutions provider Flex (NASDAQ:FLEX) fell 5.5% in the afternoon session after investors ...